Patents Assigned to CIS bio International
  • Patent number: 9024022
    Abstract: The invention relates to compounds of formula (I?): in which A, L2, M and B are as defined in the description. These compounds are substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: May 5, 2015
    Assignee: Cis Bio International
    Inventors: Emmanuel Bourrier, Michel Laget, Laurent Lamarque, Norbert Tinel, Eric Trinquet, Hervé Bazin
  • Patent number: 8999653
    Abstract: The instant invention provides for methods for detecting the internalization of a transmembrane protein of interest expressed at the surface of a cell. More specifically, the methods involve (a) labelling the protein of interest with a fluorescent metal complex, the lifetime of which is greater than 0.1 ms, (b) adding to the reaction medium a composition capable of causing the internalization of the protein of interest, (c) adding to the reaction medium (1) a modulating agent which is a fluorescent FRET acceptor compound compatible with the fluorescent metal complex, the final concentration of which in the reaction medium is greater than 10?7M; or (2) a reducing agent, the redox potential of which is less than +0.1 V and preferably between 0.25 and 0.
    Type: Grant
    Filed: July 30, 2009
    Date of Patent: April 7, 2015
    Assignee: Cis-Bio International
    Inventors: Jurriaan Zwier, Robert Poole, Herve Ansanay, Michel Fink, Eric Trinquet
  • Patent number: 8697372
    Abstract: The invention relates to a method for determining whether a test compound binds preferentially to a membrane receptor R1 or to a membrane receptor R2, these receptors being known to be expressed on the surface of the cells in monomeric, homodimeric or heterodimeric form. This method is applied using one or two FRET partner pairs.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: April 15, 2014
    Assignees: CIS Bio International, Centre National de la Recherche Scientifique
    Inventors: Eric Trinquet, Jurriaan Zwier, Gérard Mathis, Jean-Philippe Pin, Thierry Durroux
  • Patent number: 8697380
    Abstract: The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT-domain proteins expressed in cell membranes present in a measuring medium, said dimer consisting of a first protein and of a second protein, said proteins being identical or different, wherein this method comprises the following steps: (a) labeling the first and second proteins in the N-terminal portion of their VFT domains with the members of a pair of FRET partners, the Förster radius (R0) of said pair being between 20 and 55 ?; (b) measuring the FRET signal in the absence and in the presence of the test compound within a predetermined time window; (c) selecting the test compound as a modulating compound if a difference in FRET signal in the absence and in the presence of test compound is measured in step (b). The invention can be used in the search for new medicaments and new taste modulators.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: April 15, 2014
    Assignees: CIS Bio International, Centre National de la Recherche Scientifique
    Inventors: Etienne Doumazane, Jurriaan Zwier, Eric Trinquet, Jean-Phillippe Pin
  • Patent number: 8663928
    Abstract: Method for the detection in homogeneous medium of a post-translational modification of a proteinaceous substrate catalyzed by a cell enzyme, characterized in that the post-translational modification reaction takes place in intact living cells, in that these cells comprise a heterologous expression vector coding for a fusion protein comprising the proteinaceous substrate and a first coupling domain and in that it comprises the following stages: (i) Incubation of the cells in the presence or in the absence of a compound to be tested capable of modulating the activity of said enzyme, (ii) Addition to the reaction medium of a first fluorescent compound member of a first pair of FRET partners covalently bonded to a coupling agent capable of binding specifically to the first coupling domain present on the proteinaceous substrate, (iii) Addition to the reaction medium of a second fluorescent compound member of this first pair of FRET partners, and covalently bonded to a binding domain specific to the site of the
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: March 4, 2014
    Assignee: CIS BIO International
    Inventors: Eric Trinquet, Achim Brinker, Emmanuel Claret, Gérard Mathis
  • Patent number: 8470523
    Abstract: The invention relates to a quantitative non-microscopic method of detecting intracellular interactions between biomolecules in living cells, in response to a biological or pharmacological stimulation, by a time-resolved proximate energy transfer effect between two members of a fluorescence donor/acceptor pair.
    Type: Grant
    Filed: September 4, 2006
    Date of Patent: June 25, 2013
    Assignee: CIS BIO International
    Inventors: Iris Pribilla, Hervé Bazin, Sraboni Ghose, Norbert Tinel, Michel Fink, Eric Trinquet, Gérard Mathis
  • Patent number: 8361715
    Abstract: The invention relates to a method for suppressing the FRET emitted by a reaction medium containing a pair of fluorescent FRET partner conjugates specific for a biological event, characterized in that a FRET signal killer which does not disturb said biological event is introduced into this medium.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: January 29, 2013
    Assignee: CIS Bio International
    Inventors: Gérard Mathis, Eric Trinquet, Patrizia Alberti, Michel Laget
  • Publication number: 20120190048
    Abstract: The invention relates to a method for determining whether a test compound binds preferentially to a membrane receptor R1 or to a membrane receptor R2, these receptors being known to be expressed on the surface of the cells in monomeric, homodimeric or heterodimeric form. This method is applied using one or two FRET partner pairs.
    Type: Application
    Filed: August 12, 2010
    Publication date: July 26, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CIS BIO INTERNATIONAL
    Inventors: Eric Trinquet, Jurriaan Zwier, Gérard Mathis, Jean-Philippe Pin, Thierry Durroux
  • Patent number: 8178704
    Abstract: The present invention relates to inositol phosphate derivatives, in which the inositol phosphate is substituted with one or two reactive groups G or one or two conjugated substances or molecules M, said reactive group(s) G or said substance(s) or molecule(s) M being linked to IP1 via a linkage group L, M being chosen from the following group: a tracer, an immunogen, a member of a binding partner pair, a solid support. Application: tools allowing the study of the inositol phosphate cycle and therefore, indirectly, the study of seven transmembrane domain receptors coupled to phospholipase C, receptors having a tyrosine kinase activity, and in general enzymes involved in the variations of the intracellular concentration of IP1.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: May 15, 2012
    Assignee: CIS Bio International
    Inventors: Hervé Bazin, Hervé Ansanay, Eric Trinquet, Gérard Mathis
  • Publication number: 20120115176
    Abstract: The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT-domain proteins expressed in cell membranes present in a measuring medium, said dimer consisting of a first protein and of a second protein, said proteins being identical or different, wherein this method comprises the following steps: (a) labeling the first and second proteins in the N-terminal portion of their VFT domains with the members of a pair of FRET partners, the Förster radius (R0) of said pair being between 20 and 55 ?; (b) measuring the FRET signal in the absence and in the presence of the test compound within a predetermined time window; (c) selecting the test compound as a modulating compound if a difference in FRET signal in the absence and in the presence of test compound is measured in step (b). The invention can be used in the search for new medicaments and new taste modulators.
    Type: Application
    Filed: April 29, 2010
    Publication date: May 10, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CIS BIO INTERNATIONAL
    Inventors: Etienne Doumazane, Jurriaan Zwier, Eric Trinquet, Jean-Phillippe Pin
  • Publication number: 20120009599
    Abstract: A method for detecting the internalization of a transmembrane protein of interest expressed at the surface of a cell, comprising the following steps: a) labelling the protein of interest with a fluorescent metal complex, the lifetime of which is greater than 0.1 ms; b) adding to the reaction medium a composition capable of causing the internalization of the protein of interest; c) adding to the reaction medium a modulating agent selected from: a. a fluorescent or nonfluorescent FRET acceptor compound compatible with said fluorescent metal complex, the final concentration of which in the reaction medium is greater than 10?7M; b. a reducing agent, the redox potential of which is less than +0.1 V and preferably between 0.25 and 0.75 V; c. an agent which binds specifically, by noncovalent bonding, with the fluorescent metal complex; d.
    Type: Application
    Filed: July 30, 2009
    Publication date: January 12, 2012
    Applicant: CIS-BIO INTERNATIONAL
    Inventors: Jurriaan Zwier, Robert Poole, Herve Ansanay, Michel Fink, Eric Trinquet
  • Publication number: 20110236952
    Abstract: The invention relates to compounds of formula (I?): in which A, L2, M and B are as defined in the description.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 29, 2011
    Applicant: CIS BIO International
    Inventors: Emmanuel Bourrier, Michel Laget, Laurent Lamarque, Norbet Tinel, Eric Trinquet, Hervé Bazin
  • Patent number: 7998694
    Abstract: The present invention relates to a method of revealing a biological process using a FRET measurement, which comprises the following steps: incorporating, into a measurement medium containing a lipid membrane, a biological entity X coupled with a first member of a pair of FRET partners and a second biological entity Y coupled with the second member of the pair of FRET partners, the energy-donating member of the pair of FRET partners having a long lifetime and the members of said pair of FRET partners being located on either side of the lipid membrane; exciting the measurement medium at the excitation wavelength of the energy-donating member; and measuring the FRET signal or the variations in said signal emitted in said culture medium.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: August 16, 2011
    Assignee: CIS BIO International
    Inventors: Eric Trinquet, Hervé Ansanay, Gérard Mathis
  • Patent number: 7872243
    Abstract: The invention concerns the use of the fluorescence polarization phenomenon to improve detection of fluorescent signals during a fluorescence resonance energy transfer (FRET). In particular, the invention concerns a method for improving signal/noise ratio in a FRET measurement. The invention also concerns an apparatus for measuring fluorescence following an energy transfer between a donor fluorescent compound and an acceptor fluorescence compound in a measurement medium.
    Type: Grant
    Filed: June 27, 2005
    Date of Patent: January 18, 2011
    Assignee: CIS BIO International
    Inventors: Eric Trinquet, Gérard Mathis
  • Patent number: 7838211
    Abstract: The invention relates to a method for determining endoglycosidase enzyme activity, and in particular of the heparanase type, in a sample, and also to a method for detecting a compound capable of modulating the activity of an endoglycosidase, and in particular of an endoglycosidase having activity of the heparanase type, by measuring a signal resulting from a close proximity transfer between two compounds attached to a substrate for the enzyme.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: November 23, 2010
    Assignee: Cis Bio International
    Inventors: Marc Preaudat, Chikashi Tokuda, Laurence Jacquemart
  • Publication number: 20100204467
    Abstract: Lanthanide (III) ion complexing compound comprising: (1) a sensitizer moiety of formula (I) in which: a is an integer from 1 to 4; b is an integer equal 1 or 2; c is an integer equal to 1 or 2; (R1)a, (R2)b, (R3)c are the same or different and are chosen from the group consisting of: H; alkyl; —COOR4 where R4 is H or an alkyl; aryl; heteroaryl; saturated or unsaturated cyclic hydrocarbon; CF3; CN; a halogen atom; L-Rg; L-Sc; or two consecutive R3, two consecutive R2 or two consecutive R1 groups together form an aryl or a heteroaryl group or a saturated or unsaturated cyclic hydrocarbon group; where L is a linker, Rg is a reactive group and Sc is a conjugated substance; X1 and X2 are the same or different and are O or S; A is either a direct bond or a divalent group chosen from —CH2— or —(CH2)2—, said moiety being covalently attached to (2) a lanthanide (III) ion chelating moiety through A. Application: Preparation of luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels.
    Type: Application
    Filed: July 18, 2008
    Publication date: August 12, 2010
    Applicant: CIS BIO INTERNATIONAL
    Inventors: Laurent Lamarque, Craig Montgomery, David Parker
  • Publication number: 20100143960
    Abstract: A subject matter of the invention is cyanine derivatives of formula: in which the dotted lines represent the atoms necessary for the formation of one or two fused aromatic rings, each ring comprising 5 or 6 carbon atoms; R1, R2, R3 and R4 represent, independently of one another: H; substituted or unsubstituted C1-C15 alkyl; C1-C6 alkoxy; (C2-C12)dialkylamino; C1-C6 alkoxycarbonyl; di(C2-C12)alkylamido; a substituted or unsubstituted aryl, arylalkyl or aryloxy group; a halogen atom; a nitro; an L1-W, L2-M, L2-A or L2-G group; R5 and R6 represent, independently of one another: substituted or unsubstituted C1-C15 alkyl; a substituted or unsubstituted aryl or arylalkyl group; an L1-W, L2-M, L2-A or L2-G group; X is chosen from: O, S or CR7R8; Y is chosen from: O, S or CR9R10; R7, R8, R9 and R10 independently represent: substituted or unsubstituted C1-C15 alkyl; substituted or unsubstituted aryl, arylalkyl or aryloxy; an L1-W, L2-M, L2-A or L2-G group; R7 and R8 and/or R9 and R10 can also together form a ring
    Type: Application
    Filed: March 7, 2008
    Publication date: June 10, 2010
    Applicant: CIS BIO INTERNATIONAL
    Inventor: Herve Bazin
  • Publication number: 20100086943
    Abstract: Method for the detection in homogeneous medium of a post-translational modification of a protein substrate catalyzed by a cell enzyme, characterized in that the post-translational modification reaction takes place in intact living cells, in that these cells comprise a heterologous expression vector coding for a fusion protein comprising the protein substrate and a first coupling domain and in that it comprises the following stages: (v) Incubation of the cells in the presence or in the absence of a compound to be tested capable of modulating the activity of said enzyme, (vi) Addition to the reaction medium of a first fluorescent compound member of a first pair of FRET partners covalently bonded to a coupling agent capable of binding specifically to the first coupling domain present on the protein substrate, (vii) Addition to the reaction medium of a second fluorescent compound member of this first pair of FRET partners, and covalently bonded to a binding domain specific to the site of the protein substrate hav
    Type: Application
    Filed: November 27, 2007
    Publication date: April 8, 2010
    Applicant: CIS BIO INTERNATIONAL
    Inventors: Eric Trinquet, Achim Brinker, Emmanuel Claret, Gérard Mathis
  • Patent number: 7659364
    Abstract: The synthesis of N-methyl-homocysteines and their use are described.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: February 9, 2010
    Assignee: CIS Bio International
    Inventors: Marc Willuhn, Johannes Platzek, Eckhard Ottow, Orlin Petrov, Claudia Borm, Dirk Hinz, Gregor Mann, John Lister-James, David M. Wilson
  • Publication number: 20090294691
    Abstract: The invention concerns the use of the fluorescence polarization phenomenon to improve detection of fluorescent signals during a fluorescence resonance energy transfer (FRET). In particular, the invention concerns a method for improving signal/noise ratio in a FRET measurement. The invention also concerns an apparatus for measuring fluorescence following an energy transfer between a donor fluorescent compound and an acceptor fluorescence compound in a measurement medium.
    Type: Application
    Filed: June 27, 2005
    Publication date: December 3, 2009
    Applicant: CIS BIO INTERNATIONAL
    Inventors: Eric Trinquet, Gerard Mathis